Filing Details

Accession Number:
0001209191-17-052893
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-09-14 21:21:09
Reporting Period:
2017-09-12
Accepted Time:
2017-09-14 21:21:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1435049 Aduro Biotech Inc. ADRO Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1465994 Jennifer Lew C/O Aduro Biotech, Inc.
740 Heinz Avenue
Berkeley CA 94710
Sr. Vice President Of Finance No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-09-12 23,300 $0.00 65,895 No 4 A Direct
Common Stock Disposition 2017-09-13 3,557 $10.99 62,338 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. Represents grant of restricted stock units payable in common stock that vest in four equal annual installments from the grant date of September 12, 2017.
  2. The shares were sold to cover the tax obligation that occurred upon the vesting of an RSU.